Explore

TrendlineTrendline
Drug Firms' Proprietary Data Significantly Boost AI Protein Model Performance

Drug Firms' Proprietary Data Significantly Boost AI Protein Model Performance

Drug Firms' Proprietary Data Significantly Boost AI Protein Model Performance
Rapid ReadRapid Read
RUI Project Focuses on Mass Spectrometry Simulations for Post-Translational Modifications

RUI Project Focuses on Mass Spectrometry Simulations for Post-Translational Modifications

A scientific project, RUI: Simulations of MS Spectra, is actively engaged in simulating mass spectrometry (MS) spectra. The primary objective of this research is to thoroughly examine post-translational modifications (PTMs) and nucleosides. This initiative aims to develop advanced computational models that can accurately predict how various modifications to proteins and nucleic acids will appear in mass spectrometry data. By focusing on the most commonly observed PTMs, the project seeks to enhance the understanding and identification of these crucial biological processes. The simulations are designed to provide a detailed theoretical framework that complements experimental mass spectrometry, allowing researchers to better interpret complex spectral data. This work is fundamental for advancing proteomics and nucleosides research, offering new tools for analyzing the intricate molecular landscape within biological systems. The project's methodology involves creating sophisticated algorithms to model the frag...
TrendlineTrendline
Arm Holdings CEO Rene Haas Predicts AI Will Cure Cancer, Drawing Expert Criticism

Arm Holdings CEO Rene Haas Predicts AI Will Cure Cancer, Drawing Expert Criticism

Arm Holdings CEO Rene Haas Predicts AI Will Cure Cancer, Drawing Expert Criticism
TrendlineTrendline
Therna Biosciences Launches Chronos Data Engine to Advance AI RNA Biologist Platform

Therna Biosciences Launches Chronos Data Engine to Advance AI RNA Biologist Platform

Therna Biosciences Launches Chronos Data Engine to Advance AI RNA Biologist Platform
Rapid ReadRapid Read
BostonGene Expands AI-Powered Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research

BostonGene Expands AI-Powered Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research

BostonGene, a developer of AI models for tumor and immune biology, has expanded its scientific collaboration with the Dana-Farber Cancer Institute. This expanded partnership aims to deepen the understanding of the complex biological mechanisms driving BRCA1- and BRCA2-associated breast cancers. The collaboration will utilize BostonGene's foundation model of tumor and immune biology and multimodal AI analytics to place individual tumors within a broader biological context. This approach seeks to systematically discover mechanisms that differentiate disease subtypes, drive therapeutic response, and contribute to resistance. The research will focus on BRCA1/2-associated ER-positive breast cancer (BRCA ER+), TP53-mutant ER-positive breast cancer (TP53 ER+), and triple-negative breast cancer (TNBC).
TheStreetTheStreet
Qualcomm now faces rival with bigger market cap

Qualcomm now faces rival with bigger market cap

Another chipmaker's newest processor claims faster AI and stronger gaming performance.
TrendlineTrendline
J.P. Morgan Asset Management Warns Investors on AI Exposure and Diversification Risks

J.P. Morgan Asset Management Warns Investors on AI Exposure and Diversification Risks

J.P. Morgan Asset Management Warns Investors on AI Exposure and Diversification Risks
TrendlineTrendline
NVIDIA Accused of Greenwashing Amidst Soaring Indirect Emissions

NVIDIA Accused of Greenwashing Amidst Soaring Indirect Emissions

NVIDIA Accused of Greenwashing Amidst Soaring Indirect Emissions
Rapid ReadRapid Read
Chinese AI Chatbots Compete with U.S. Models While Avoiding Sensitive Topics

Chinese AI Chatbots Compete with U.S. Models While Avoiding Sensitive Topics

Chinese AI chatbots are demonstrating increasing competitiveness with leading U.S. models like Anthropic's Claude and OpenAI's ChatGPT, often offering lower usage costs. These open-source Chinese models have gained users in the U.S. and other countries. However, a notable characteristic of these Chinese AI systems is their silence on topics deemed sensitive by Beijing. For instance, when asked about the Tiananmen Square crackdown on June 4, 1989, DeepSeek responds with "I'm not able to help with that," while it can provide details on the September 11, 2001, attacks in the United States. This behavior is consistent with China's cybersecurity regulator's processes for approving new generative AI services, particularly those that could influence public opinion. The Chinese government views integrating AI across industries as a significant part of its economic development plans for the next five years.
ReutersReuters
Wall Street futures edge higher in countdown to Fed decision

Wall Street futures edge higher in countdown to Fed decision

By Niket Nishant and Tharuniyaa Lakshmi Sept 16 (Reuters) - U.S. stock index futures attempted a recovery on Wednesday following a two-day slide, as lower oil prices offered some relief during a tense wait for the Federal Reserve's interest rate decision.
TrendlineTrendline
Viva Biotech Advances Cyclic Peptide Drug Development with AI and Hybrid Synthesis Methods

Viva Biotech Advances Cyclic Peptide Drug Development with AI and Hybrid Synthesis Methods

Viva Biotech Advances Cyclic Peptide Drug Development with AI and Hybrid Synthesis Methods
TrendlineTrendline
Viva Biotech Discusses Challenges and Opportunities in Cyclic Peptide Drug Development and Manufacturing

Viva Biotech Discusses Challenges and Opportunities in Cyclic Peptide Drug Development and Manufacturing

Viva Biotech Discusses Challenges and Opportunities in Cyclic Peptide Drug Development and Manufacturing